# Sublingual Misoprostol Versus No Cervical Priming Before Hysteroscopic Resection of Symptomatic Uterine Niches

> **NCT07271056** · NA · COMPLETED · sponsor: **Benha University** · enrollment: 56 (actual)

## Conditions studied

- Scar Niche
- Abnormal Uterine Bleeding
- Cesarean Section Complications

## Interventions

- **DRUG:** Misoprostol 200mcg Tab
- **OTHER:** Placebo tab
- **PROCEDURE:** Hysteroscopic resection of uterine niche
- **DIAGNOSTIC_TEST:** Saline-infusion Sonohysterography

## Key facts

- **NCT ID:** NCT07271056
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-11
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07271056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07271056, "Sublingual Misoprostol Versus No Cervical Priming Before Hysteroscopic Resection of Symptomatic Uterine Niches". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07271056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*